|
1
|
Lopez NE, Weiss AC, Robles J, Fanta P and
Ramamoorthy SL: A systematic review of clinically available gene
expression profiling assays for stage II colorectal cancer: Initial
steps toward genetic staging. Am J Surg. 212:700–714. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gall TM, Markar SR, Jackson D, Haji A and
Faiz O: Mini-probe ultrasonography for the staging of colon cancer:
A systematic review and meta-analysis. Colorectal Dis. 16:O1–O8.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim HD, Ha KS, Woo IS, Jung YH, Han CW and
Kim TJ: Tumor lysis syndrome in a patient with metastatic colon
cancer after treatment with 5-fluorouracil/leucovorin and
oxaliplatin: Case report and literature review. Cancer Res Treat.
46:204–207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tudyka V, Blomqvist L, Beets-Tan RG,
Boelens PG, Valentini V, van de Velde CJ, Dieguez A and Brown G:
EURECCA consensus conference highlights about colon & rectal
cancer multidisciplinary management: The radiology experts review.
Eur J Surg Oncol. 40:469–475. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sheets N, Powers J and Richmond B:
Cutaneous metastasis of colon cancer: Case report and literature
review. W V Med J. 110:22–24. 2014.PubMed/NCBI
|
|
6
|
Bockelman C, Engelmann BE, Kaprio T,
Hansen TF and Glimelius B: Risk of recurrence in patients with
colon cancer stage II and III: A systematic review and
meta-analysis of recent literature. Acta Oncol. 54:5–16. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moilanen JM, Löffek S, Väyrynen JP,
Syväniemi E, Hurskainen T, Mäkinen M, Klintrup K, Mäkelä J,
Sormunen R, et al: Collagen XVII expression correlates with the
invasion and metastasis of colorectal cancer. Hum Pathol.
46:434–442. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan Z, Cui H, Xu X, Lin Z, Zhang X, Kang
L, Han B, Meng J, Yan Z, Yan X and Jiao S: MiR-125a suppresses
tumor growth, invasion and metastasis in cervical cancer by
targeting STAT3. Oncotarget. 6:25266–25280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tian M, Wan Y, Tang J, Li H, Yu G, Zhu J,
Ji S, Guo H, Zhang N, Li W, et al: Depletion of tissue factor
suppresses hepatic metastasis and tumor growth in colorectal cancer
via the downregulation of MMPs and the induction of autophagy and
apoptosis. Cancer Biol Ther. 12:896–907. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu K: Role of apoptosis resistance in
immune evasion and metastasis of colorectal cancer. World J
Gastrointest Oncol. 2:399–406. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang XB, Song L, Wen HJ, Bai XX, Li ZJ
and Ma LJ: Upregulation of microRNA-31 targeting integrin α5
suppresses tumor cell invasion and metastasis by indirectly
regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.
Tumour Biol. 37:8317–8325. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo J, Yu X, Gu J, Lin Z, Zhao G, Xu F, Lu
C and Ge D: Regulation of CXCR4/AKT-signaling-induced cell invasion
and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal
cancer. Tumour Biol. 37:6371–6378. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang N, Deng JY, Liu Y, Ke B, Liu HG and
Liang H: Incorporation of perineural invasion of gastric carcinoma
into the 7th edition tumor-node-metastasis staging system. Tumour
Biol. 35:9429–9436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bukurova IuA, Khankin SL, Krasnov GS,
Grigor'eva ES, Mashkova TD, Lisitsin NA, Karpov VL and Beresten'
SF: Comparison of 2D analysis and bioinformatics search efficiency
for colon cancer marker identification. Mol Biol. 44:375–381.
2010.(In Russian). View Article : Google Scholar
|
|
15
|
Thompson BA, Goldgar DE, Paterson C,
Clendenning M, Walters R, Arnold S, Parsons MT, Michael DW,
Gallinger S, Haile RW, et al: A multifactorial likelihood model for
MMR gene variant classification incorporating probabilities based
on sequence bioinformatics and tumor characteristics: A report from
the Colon Cancer Family Registry. Hum Mutat. 34:200–209. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee JS, Jung WK, Jeong MH, Yoon TR and Kim
HK: Sanguinarine induces apoptosis of HT-29 human colon cancer
cells via the regulation of Bax/Bcl-2 ratio and caspase-9-dependent
pathway. Int J Toxicol. 31:70–77. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grosse-Wilde A, Voloshanenko O, Bailey SL,
Longton GM, Schaefer U, Csernok AI, Schütz G, Greiner EF, Kemp CJ
and Walczak H: TRAIL-R deficiency in mice enhances lymph node
metastasis without affecting primary tumor development. J Clin
Invest. 118:100–110. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ndebele K, Gona P, Jin TG, Benhaga N,
Chalah A, Degli-Esposti M and Khosravi-Far R: Tumor necrosis factor
(TNF)-related apoptosis-inducing ligand (TRAIL) induced
mitochondrial pathway to apoptosis and caspase activation is
potentiated by phospholipid scramblase-3. Apoptosis. 13:845–856.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ivanov VN, Bhoumik A and Ronai Z: Death
receptors and melanoma resistance to apoptosis. Oncogene.
22:3152–3161. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang XD, Franco A, Myers K, Gray C,
Nguyen T and Hersey P: Relation of TNF-related apoptosis-inducing
ligand (TRAIL) receptor and FLICE-inhibitory protein expression to
TRAIL-induced apoptosis of melanoma. Cancer Res. 59:2747–2753.
1999.PubMed/NCBI
|
|
21
|
Qiu B, Sun X, Zhang D, Wang Y, Tao J and
Ou S: TRAIL and paclitaxel synergize to kill U87 cells and
U87-derived stem-like cells in vitro. Int J Mol Sci. 13:9142–9156.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang XD, Franco AV, Nguyen T, Gray CP and
Hersey P: Differential localization and regulation of death and
decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL)
in human melanoma cells. J Immunol. 164:3961–3970. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Skinner SO, Xu H, Nagarkar-Jaiswal S,
Freire PR, Zwaka TP and Golding I: Single-cell analysis of
transcription kinetics across the cell cycle. Elife. 5:e121752016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bai FL, Yu YH, Tian H, Ren GP, Wang H,
Zhou B, Han XH, Yu QZ and Li DS: Genetically engineered Newcastle
disease virus expressing interleukin-2 and TNF-related
apoptosis-inducing ligand for cancer therapy. Cancer Biol Ther.
15:1226–1238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wai-Hoe L, Wing-Seng L, Ismail Z and
Lay-Harn G: SDS-PAGE-based quantitative assay for screening of
kidney stone disease. Biol Proced Online. 11:145–160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Saito T, Morohashi H, Hasebe T, Sakamoto
Y, Koyama M, Murata A and Hakamada K: A review of stereotactic
radiotherapy (SRT) for lung metastasis of colon cancer. Gan To
Kagaku Ryoho. 41:1462–1464. 2014.(In Japanese). PubMed/NCBI
|
|
28
|
Kojima Y, Nakayama M, Nishina T, Nakano H,
Koyanagi M, Takeda K, Okumura K and Yagita H: Importin β1
protein-mediated nuclear localization of death receptor 5 (DR5)
limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing
ligand (TRAIL)-induced cell death of human tumor cells. J Biol
Chem. 286:43383–43393. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen L, Meng Y, Guo X, Sheng X, Tai G,
Zhang F, Cheng H and Zhou Y: Gefitinib enhances human colon cancer
cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated
death receptors upregulation. Apoptosis. 21:1291–1301. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo X, Meng Y, Sheng X, Guan Y, Zhang F,
Han Z, Kang Y, Tai G, Zhou Y and Cheng H: Tunicamycin enhances
human colon cancer cells to TRAIL-induced apoptosis by
JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR
pathway. Anticancer Drugs. 28:66–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen L, Meng Y, Sun Q, Zhang Z, Guo X,
Sheng X, Tai G, Cheng H and Zhou Y: Ginsenoside compound K
sensitizes human colon cancer cells to TRAIL-induced apoptosis via
autophagy-dependent and -independent DR5 upregulation. Cell Death
Dis. 7:e23342016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gupta SC, Reuter S, Phromnoi K, Park B,
Hema PS, Nair M and Aggarwal BB: Nimbolide sensitizes human colon
cancer cells to TRAIL through reactive oxygen species- and
ERK-dependent up-regulation of death receptors, p53, and Bax. J
Biol Chem. 291:169252016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bousserouel S, Le Grandois J, Gossé F,
Werner D, Barth SW, Marchioni E, Marescaux J and Raul F: Methanolic
extract of white asparagus shoots activates TRAIL apoptotic death
pathway in human cancer cells and inhibits colon carcinogenesis in
a preclinical model. Int J Oncol. 43:394–404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee SC, Cheong HJ, Kim SJ, Yoon J, Kim HJ,
Kim KH, Kim SH, Kim HJ, Bae SB, Kim CK, et al: Low-dose
combinations of LBH589 and TRAIL can overcome TRAIL-resistance in
colon cancer cell lines. Anticancer Res. 31:3385–3394.
2011.PubMed/NCBI
|
|
35
|
Hwang JS, Lee HC, Oh SC, Lee DH and Kwon
KH: Shogaol overcomes TRAIL resistance in colon cancer cells via
inhibiting of survivin. Tumour Biol. 36:8819–8829. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Woo JK, Kang JH, Jang YS, Ro S, Cho JM,
Kim HM, Lee SJ and Oh SH: Evaluation of preventive and therapeutic
activity of novel non-steroidal anti-inflammatory drug, CG100649,
in colon cancer: Increased expression of TNF-related
apoptosis-inducing ligand receptors enhance the apoptotic response
to combination treatment with TRAIL. Oncol Rep. 33:1947–1955. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Moriwaki K, Shinzaki S and Miyoshi E:
GDP-mannose-4,6-dehydratase (GMDS) deficiency renders colon cancer
cells resistant to tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL) receptor- and CD95-mediated apoptosis by inhibiting
complex II formation. J Biol Chem. 286:43123–43133. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Skender B, Hofmanová J, Slavík J,
Jelínková I, Machala M, Moyer MP, Kozubík A and Hyršlová Vaculová
A: DHA-mediated enhancement of TRAIL-induced apoptosis in colon
cancer cells is associated with engagement of mitochondria and
specific alterations in sphingolipid metabolism. Biochim Biophys
Acta. 1841:1308–1317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Edagawa M, Kawauchi J, Hirata M, Goshima
H, Inoue M, Okamoto T, Murakami A, Maehara Y and Kitajima S: Role
of activating transcription factor 3 (ATF3) in endoplasmic
reticulum (ER) stress-induced sensitization of p53-deficient human
colon cancer cells to tumor necrosis factor (TNF)-related
apoptosis-inducing ligand (TRAIL)-mediated apoptosis through
up-regulation of death receptor 5 (DR5) by zerumbone and celecoxib.
J Biol Chem. 289:21544–21561. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Screpanti V, Wallin RP, Grandien A and
Ljunggren HG: Impact of FASL-induced apoptosis in the elimination
of tumor cells by NK cells. Mol Immunol. 42:495–499. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Contassot E, Kerl K, Roques S, Shane R,
Gaide O, Dupuis M, Rook AH and French LE: Resistance to FasL and
tumor necrosis factor-related apoptosis-inducing ligand-mediated
apoptosis in Sezary syndrome T-cells associated with impaired death
receptor and FLICE-inhibitory protein expression. Blood.
111:4780–4787. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kamoshida G, Matsuda A, Miura R, Takashima
Y, Katsura A and Tsuji T: Potentiation of tumor cell invasion by
co-culture with monocytes accompanying enhanced production of
matrix metalloproteinase and fibronectin. Clin Exp Metastasis.
30:289–297. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tuncel H, Shimamoto F, Cagatay P and
Kalkan MT: Variable E-cadherin expression in a MNU-induced colon
tumor model in rats which exposed with 50 Hz frequency sinusoidal
magnetic field. Tohoku J Exp Med. 198:245–249. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Muller N, Reinacher-Schick A, Baldus S,
van Hengel J, Berx G, Baar A, van Roy F, Schmiegel W and
Schwarte-Waldhoff I: Smad4 induces the tumor suppressor E-cadherin
and P-cadherin in colon carcinoma cells. Oncogene. 21:6049–6058.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Dmello C, Sawant S, Alam H, Gangadaran P,
Tiwari R, Dongre H, Rana N, Barve S, Costea DE, Chaukar D, et al:
Vimentin-mediated regulation of cell motility through modulation of
beta4 integrin protein levels in oral tumor derived cells. Int J
Biochem Cell Biol. 70:161–172. 2016. View Article : Google Scholar : PubMed/NCBI
|
